Zoetis ZTS
NYSE ZTS
$73.39 -0.17 (-0.22%)
As of: Sep 9, 2026 · 2:24 PM EDT

Zoetis (ZTS) Income towards Parent Company (2012 - 2026)

Zoetis' (ZTS) quarterly Income towards Parent Company came in at $866.0 million in Q2 2026, down 5.04% year-over-year from $912.0 million in Q2 2025, and up 14.25% quarter-over-quarter from $758.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Income towards Parent Company (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Income towards Parent Company for 15 consecutive years, with $866.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income towards Parent Company fell 5.04% year-over-year to $866.0 million in Q2 2026; TTM through Jun 2026 was $3.3 billion, a 0.58% decrease from a year earlier, with the FY2025 full-year figure at $3.4 billion, up 7.25% from the prior year.
  • Income towards Parent Company was $866.0 million for Q2 2026 at Zoetis, up from $758.0 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $912.0 million in Q2 2025 and troughed at $592.0 million in Q4 2022.
  • A 5-year average of $760.1 million and a median of $752.5 million in 2024 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company soared 30.15% in 2023 and slipped 10.55% in 2024, its largest moves.
  • Over 5 years, Income towards Parent Company stood at $592.0 million in 2022, then climbed by 9.8% to $650.0 million in 2023, then increased by 12.62% to $732.0 million in 2024, then rose by 3.96% to $761.0 million in 2025, then grew by 13.8% to $866.0 million in 2026.
  • The last three Income towards Parent Company figures came in at $866.0 million (Q2 2026), $758.0 million (Q1 2026), and $761.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.55 Bn 40.36 Bn 779.09 Mn
2 Zoetis 30.68 Bn 29.00 Bn 1.05 Bn
3 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
4 Phibro Animal Health 1.50 Bn 1.42 Bn 134.40 Mn
5 Immucell 89.92 Mn 81.06 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 75.05 Mn 67.96 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 866.00 Mn
Mar 31, 2026 758.00 Mn
Dec 31, 2025 761.00 Mn
Sep 30, 2025 887.00 Mn
Jun 30, 2025 912.00 Mn
Mar 31, 2025 773.00 Mn
Dec 31, 2024 732.00 Mn
Sep 30, 2024 874.00 Mn
Jun 30, 2024 780.00 Mn
Mar 31, 2024 747.00 Mn
Dec 31, 2023 650.00 Mn
Sep 30, 2023 717.00 Mn
Jun 30, 2023 872.00 Mn
Mar 31, 2023 697.00 Mn
Dec 31, 2022 592.00 Mn
Sep 30, 2022 667.00 Mn
Jun 30, 2022 670.00 Mn
Mar 31, 2022 727.00 Mn
Dec 31, 2021 506.00 Mn
Sep 30, 2021 659.00 Mn